STONE CHRISTOPHER LEWIS (VP, Gen. Counsel & Secretary) reported 2 transactions at PDL BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/28/2018ACC: 0000882104-18-000129
Officer· VP, Gen. Counsel & Secretary
Since Sep 2018
-231.84K
Net shares
Net seller
$10.8K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
231.84K disposed
Non-Derivative Transactions2
Common stock
Direct
Shares
−3.58K
Price / share
$3.02
Trade value
$10.81K
% of position
0.8%
12/27/2018
430.79K→427.21K
Common stock
Direct
Shares
−228.25K
Price / share
—
Trade value
—
% of position
53.4%
12/27/2018
427.21K→198.95K
Total
Net shares
−231.84K
Net value
-$10.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 12/27/2018 | F · Tax Withholding | −3.58K | $3.02 | $10.81K | 0.8% | 430.79K | 427.21K |
| Common stock Direct | 12/27/2018 | D · Disposition | −228.25K | — | — | 53.4% | 427.21K | 198.95K |
| Total | −231.84K | -$10.81K | ||||||
Derivative Transactions0
No derivative transactions reported